LAVA Therapeutics NV
LVTX1.400USD
-0.020-1.41%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
36.83MMarket Cap
LossP/E TTM
LAVA Therapeutics NV
1.400
-0.020-1.41%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2020H2
FY2020H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-1281.38%-11.64M
-15.81%-8.63M
35.83%-8.38M
89.89%-843.00K
-128.32%-10.12M
48.05%-7.45M
-34.41%-13.06M
-9.27%-8.34M
--35.73M
---14.34M
---9.72M
---7.63M
---11.69M
--1.59M
Net income from continuing operations
-472.20%-3.48M
-38.85%-12.20M
34.85%-8.21M
95.62%-608.00K
56.88%-6.44M
-941.57%-8.79M
-73.19%-12.60M
-32.14%-13.87M
---14.93M
--1.04M
---7.28M
---10.50M
---7.56M
---7.87M
Operating gains losses
-25.69%107.00K
-33.33%212.00K
-22.71%228.00K
-53.99%144.00K
29.89%352.00K
89.29%318.00K
69.54%295.00K
86.31%313.00K
--271.00K
--168.00K
--174.00K
--168.00K
--272.64K
--188.39K
Other non-cash items
-453.65%-5.30M
171.82%1.04M
-51.89%-1.00M
-301.26%-958.00K
-67.74%1.15M
44.47%-1.46M
81.89%-661.00K
232.59%476.00K
--3.57M
---2.62M
---3.65M
---359.00K
--224.25K
--295.26K
Change in working capital
-463.16%-3.64M
-18.40%1.30M
91.47%-133.00K
-120.28%-646.00K
-113.16%-6.05M
111.69%1.60M
-270.57%-1.56M
259.59%3.19M
--45.98M
---13.67M
--914.00K
--886.00K
---4.86M
--8.70M
-Change in receivables
----
-94.35%164.00K
89.40%-254.00K
-41.10%758.00K
-100.43%-206.00K
105.81%2.91M
-4709.62%-2.40M
946.71%1.29M
--47.60M
---49.97M
--52.00K
---152.00K
---1.15M
---37.46K
-Change in prepaid expenses
-139.70%-478.00K
357.88%704.00K
-146.33%-947.00K
3.08%1.20M
115.38%446.00K
56.04%-273.00K
193.26%2.04M
20.91%1.17M
---2.90M
---621.00K
--697.00K
--966.00K
----
----
-Change in other current assets
----
----
----
--57.00K
----
----
----
----
--106.00K
--16.00K
---122.00K
----
---727.04K
---26.44K
-Change in other current liabilities
----
134.86%1.90M
109.73%307.00K
-153.86%-887.00K
-144.27%-1.18M
-115.91%-5.45M
-2148.05%-3.15M
5090.91%1.65M
--2.66M
--34.25M
--154.00K
---33.00K
---2.28M
--7.86M
Cash from non-recurring investing activities
Cash from operating activities
-1281.38%-11.64M
-15.81%-8.63M
35.83%-8.38M
89.89%-843.00K
-128.32%-10.12M
48.05%-7.45M
-34.41%-13.06M
-9.27%-8.34M
--35.73M
---14.34M
---9.72M
---7.63M
---11.69M
--1.59M
Investing cash flow
Net cash from continuing investing activities
----
250.00%21.00K
-101.34%-3.00K
-113.20%-66.00K
-100.00%0.00
124.00%6.00K
833.33%224.00K
54.80%500.00K
--265.00K
---25.00K
--24.00K
--323.00K
--347.00K
--157.55K
Capital expenditures
----
283.33%23.00K
----
-95.40%23.00K
-100.00%0.00
--6.00K
833.33%224.00K
54.80%500.00K
--265.00K
----
--24.00K
--323.00K
--347.00K
--157.55K
Net cash flow from disposal of fixed assets
----
250.00%21.00K
-101.34%-3.00K
-113.20%-66.00K
-100.00%0.00
124.00%6.00K
833.33%224.00K
54.80%500.00K
--265.00K
---25.00K
--24.00K
--323.00K
--347.00K
--157.55K
Net cash flow from investment products
2313.85%15.16M
102.78%468.00K
-25.00%336.00K
-92.32%628.00K
-124.24%-8.69M
-356.83%-16.84M
-87.40%448.00K
121.36%8.18M
---3.87M
--6.56M
--3.56M
--3.69M
----
----
Net cash flow from other investing activities
----
----
----
----
----
----
----
----
----
----
----
----
--1.18K
---1.10K
Cash from non-current investing activities
Net cash flow from investing activities
2084.29%15.16M
102.65%447.00K
51.34%339.00K
-90.96%694.00K
-109.88%-8.69M
-355.95%-16.85M
-93.66%224.00K
127.74%7.68M
---4.14M
--6.58M
--3.53M
--3.37M
---345.81K
---158.65K
Financing cash flow
Cash flow from continuous financing activities
-100.00%0.00
-168.61%-368.00K
103.18%5.00K
108.25%8.00K
-1025.00%-180.00K
-1857.14%-137.00K
-536.11%-157.00K
-135.93%-97.00K
---16.00K
---7.00K
--36.00K
--270.00K
--18.03M
--847.22K
Net cash flow from debt Issuance/repayment
----
-170.07%-370.00K
92.36%-12.00K
91.75%-8.00K
-1025.00%-180.00K
-1857.14%-137.00K
-847.62%-157.00K
-135.93%-97.00K
---16.00K
---7.00K
--21.00K
--270.00K
--971.35K
--847.22K
Proceeds from stock option exercised by employees
-100.00%0.00
--2.00K
--17.00K
--8.00K
----
----
----
----
--0.00
--0.00
--15.00K
----
----
----
Net cash flow from other financing activities
----
----
----
----
----
----
----
----
----
----
----
----
--21.87M
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.00%0.00
-168.61%-368.00K
103.18%5.00K
108.25%8.00K
-1025.00%-180.00K
-1857.14%-137.00K
-536.11%-157.00K
-135.93%-97.00K
---16.00K
---7.00K
--36.00K
--270.00K
--18.03M
--847.22K
Net cash flow
Beginning cash balance
-20.84%35.02M
--35.09M
-57.07%43.19M
-55.92%44.23M
-2.59%62.66M
-100.00%0.00
17.36%100.60M
10.41%100.33M
--64.33M
--75.87M
--85.72M
--90.87M
--10.19M
--7.35M
Current period cash flow changes
546.26%4.66M
67.44%-8.12M
37.67%-8.10M
-485.24%-1.04M
-151.20%-18.43M
-116.25%-24.94M
-31.87%-13.00M
105.27%271.00K
--36.00M
---11.54M
---9.86M
---5.15M
--5.36M
--1.98M
Effect of exchange rate changes
226.80%1.15M
184.58%428.00K
-6200.00%-61.00K
-188.01%-903.00K
-87.45%555.00K
86.57%-506.00K
100.03%1.00K
188.52%1.03M
--4.42M
---3.77M
---3.70M
---1.16M
---633.80K
---295.26K
Ending cash balance
-8.13%39.67M
208.09%26.96M
-59.95%35.09M
-57.07%43.19M
-55.92%44.23M
-138.77%-24.94M
15.47%87.61M
17.36%100.60M
--100.33M
--64.33M
--75.87M
--85.72M
--15.73M
--9.37M
Free cash flow
-1244.69%-11.64M
-16.02%-8.65M
36.91%-8.38M
90.20%-866.00K
-128.53%-10.12M
48.01%-7.46M
-36.38%-13.29M
-11.12%-8.84M
--35.47M
---14.34M
---9.74M
---7.95M
---12.04M
--1.43M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
